Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

Janus kinase inhibitors can be paired with corticosteroids or used as monotherapy in the treatment of alopecia areata.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled ‘MagnetisMM-32’ ...

Senator Ron Johnson Exposes Government Cover-Up on COVID Vaccine Risks In a scathing Senate testimony, Senator Ron Johnson (R-WI) pulled back the curtain on what many are now call ...

A very different approach to Pfizer’s multiple voices and audience segmentation can be seen in Novartis’s campaign for ...

New research is calling for further study on a possible link between COVID-19 jabs and long-term vision issues.

What's needed is a course correction. Congress and the Trump administration can start by passing the EPIC Act. They should ...

In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...

First-line treatment with the monoclonal antibody is associated with more patients achieving robust clinical response at 3 months vs standard of care, but by 6 months no advantage remained.

The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...